Clinical Trials Browser

Interventional × Triple Negative Breast Neoplasms × pamiparib × Clear all

NCT03333915 2025-02-04

Study of the Efficacy, Safety and Pharmacokinetics of Pamiparib (BGB-290) in Participants With Advanced Solid Tumors

Phase 1/2 Completed

128 enrolled 36 charts

Triple Negative Breast Neoplasms